4.7 Article

Choice of template delivery mitigates the genotoxic risk and adverse impact of editing in human hematopoietic stem cells

期刊

CELL STEM CELL
卷 29, 期 10, 页码 1428-+

出版社

CELL PRESS
DOI: 10.1016/j.stem.2022.09.001

关键词

-

资金

  1. Telethon [E5, E4]
  2. Italian Ministry of Health [PE-2016-02363691]
  3. Italian Ministry of University and Research [20175XHBPN]
  4. EU Horizon 2020 Program (UPGRADE)
  5. Louis-Jeantet Foundation
  6. EU [819815]
  7. New York Stem Cell Foundation
  8. Lady Tata Memorial Trust International Award for Research in Leukemia
  9. European Research Council (ERC) [819815] Funding Source: European Research Council (ERC)

向作者/读者索取更多资源

This study reveals the unexpected load and persistence of AAV genomes and their fragments in gene editing using viral transduction. The accumulation of viral DNA triggers a sustained DNA damage response, leading to frequent integration in cells. Using an integrase-defective lentiviral vector can mitigate the adverse effects and improve gene editing efficiency.
Long-range gene editing by homology-directed repair (HDR) in hematopoietic stem/progenitor cells (HSPCs) often relies on viral transduction with recombinant adeno-associated viral vector (AAV) for template delivery. Here, we uncover unexpected load and prolonged persistence of AAV genomes and their fragments, which trigger sustained p53-mediated DNA damage response (DDR) upon recruiting the MRE11-RAD50-NBS1 (MRN) complex on the AAV inverted terminal repeats (ITRs). Accrual of viral DNA in cell-cycle-arrested HSPCs led to its frequent integration, predominantly in the form of transcriptionally competent ITRs, at nuclease on-and off-target sites. Optimized delivery of integrase-defective lentiviral vector (IDLV) induced lower DNA load and less persistent DDR, improving clonogenic capacity and editing efficiency in long-term repopulating HSPCs. Because insertions of viral DNA fragments are less frequent with IDLV, its choice for template delivery mitigates the adverse impact and genotoxic burden of HDR editing and should facilitate its clinical translation in HSPC gene therapy.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据